HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akiko Maekawa Selected Research

cysteinyl-leukotriene

11/2012Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.
3/2011Oxidative stress suppresses cysteinyl leukotriene generation by mouse bone marrow-derived mast cells.
1/2009Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells.
10/2004Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice.
3/2004Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akiko Maekawa Research Topics

Disease

7Inflammation (Inflammations)
01/2014 - 06/2002
4Asthma (Bronchial Asthma)
04/2013 - 10/2009
4Pneumonia (Pneumonitis)
11/2012 - 03/2004
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2014 - 10/2004
2Fibrosis (Cirrhosis)
10/2004 - 03/2004
1Aortic Dissection
01/2014
1Intracranial Aneurysm (Cerebral Aneurysm)
01/2014
1Atopic Dermatitis (Atopic Eczema)
01/2014
1Hypertension (High Blood Pressure)
01/2014
1Vascular Diseases (Vascular Disease)
01/2014
1type 2C Congenital disorder of glycosylation
10/2009
1Metaplasia
10/2009
1Respiratory Hypersensitivity
10/2009
1Eosinophilia
10/2009
1Systemic candidiasis
04/2009
1Vascular System Injuries
05/2004
1Thrombotic Thrombocytopenic Purpura
01/2004

Drug/Important Bio-Agent (IBA)

5cysteinyl-leukotrieneIBA
11/2012 - 03/2004
4LeukotrienesIBA
04/2013 - 10/2004
3leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
08/2010 - 03/2004
2Leukotriene E4IBA
04/2013 - 10/2009
2Leukotriene C4IBA
04/2013 - 10/2004
2Immunoglobulin E (IgE)IBA
11/2012 - 10/2004
2AllergensIBA
10/2009 - 01/2009
2Bleomycin (Blenoxane)FDA LinkGeneric
10/2004 - 03/2004
2cysteinyl leukotriene receptor 2IBA
10/2004 - 03/2004
2Blood Proteins (Serum Proteins)IBA
10/2004 - 06/2002
2ZymosanIBA
10/2004 - 06/2002
2von Willebrand FactorIBA
05/2004 - 01/2004
1ProstaglandinsIBA
01/2014
1E-SelectinIBA
01/2014
1N- (4- amino- 2- methylquinolin- 6- yl)- 2- (4- ethylphenoxymethyl)benzamideIBA
01/2014
1Nonsense Codon (Nonsense Mutation)IBA
01/2014
1AS604872IBA
01/2014
1Filaggrin ProteinsIBA
01/2014
1Cimetidine (Biomet)FDA LinkGeneric
01/2014
1SaltsIBA
01/2014
1Proteins (Proteins, Gene)FDA Link
01/2014
1Glutathione (Reduced Glutathione)IBA
04/2013
1Leukotriene D4IBA
04/2013
1AcidsIBA
04/2013
1LipidsIBA
04/2013
1LigandsIBA
11/2012
1CytokinesIBA
11/2012
1Adenosine Diphosphate (ADP)IBA
10/2009
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2009
1Prostaglandin D2IBA
10/2009
1ChemokinesIBA
10/2009
1Interleukin-13IBA
10/2009
1Secretory Phospholipases A2IBA
04/2009
1C-Type Lectins (C-Type Lectin)IBA
01/2009
1Arachidonic Acid (Vitamin F)IBA
01/2009
1mouse dectin-2IBA
01/2009
1AntigensIBA
10/2004
1indium-bleomycinIBA
10/2004
1Glycoproteins (Glycoprotein)IBA
05/2004
1Peptide Hydrolases (Proteases)FDA Link
01/2004
1thiamine triphosphorate (TTP)IBA
01/2004

Therapy/Procedure

1Oral Administration
01/2014
1Ligation
01/2014